Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk-factors

被引:33
作者
Guckelberger, O [1 ]
Byram, A [1 ]
Klupp, J [1 ]
Neumann, UP [1 ]
Glanemann, M [1 ]
Stockmann, M [1 ]
Neuhaus, R [1 ]
Neuhaus, P [1 ]
机构
[1] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany
关键词
arterial hypertension; coronary heart disease; diabetes mellitus; lipid metabolism; liver transplantation; overweight;
D O I
10.1111/j.1432-2277.2005.00174.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Increased prevalence of cardiovascular risk-factors in liver transplant recipients compared with pretransplant and standard population data has been acknowledged. The impact of risk-profiles on cardiovascular event rates or death, however, has not yet been established. Here we evaluate the development of risk-factors during a prospective follow-up of 10 years in 302 patients and compare numbers of coronary events with data from the German Prospective Cardiovascular Munster (PROCAM)-Score population. Prevalence of overweight (17% vs. 27%), hypertension (70% vs. 80%), and diabetes (21% vs. 25%) increased from early to late after transplantation, while elevated serum cholesterol (64% vs. 37%) and triglycerides (40% vs. 21%) became less frequent. Cardiovascular risk-profiles favoring tacrolimus over ciclosporin A based immunosuppression early after transplantation converged over time. Increased risk-scores in liver transplant recipients matched with score standardized event rates in the PROCAM population (ratio: 1.11, 95% CI: 0.53-2.03), nine events were predicted for the transplant population and oppose 10 events observed. Thus, indicating a reflection of increased cardiovascular risk-profiles in corresponding numbers of cardiovascular events.
引用
收藏
页码:967 / 974
页数:8
相关论文
共 29 条
  • [1] Ten years of liver transplantation - An evolving understanding of late graft loss
    Abbasoglu, O
    Levy, MF
    Brkic, BB
    Testa, G
    Jeyarajah, DR
    Goldstein, RM
    Husberg, BS
    Gonwa, TA
    Klintmalm, GB
    [J]. TRANSPLANTATION, 1997, 64 (12) : 1801 - 1807
  • [2] Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
    Assmann, G
    Cullen, P
    Schulte, H
    [J]. CIRCULATION, 2002, 105 (03) : 310 - 315
  • [3] Liver transplantation in cirrhotic patients with diabetes mellitus:: Midterm results, survival, and adverse events
    Blanco, JJ
    Herrero, JI
    Quiroga, J
    Sangro, B
    Gómez-Manero, N
    Pardo, F
    Cienfuegos, JA
    Prieto, J
    [J]. LIVER TRANSPLANTATION, 2001, 7 (03) : 226 - 233
  • [4] Prevention of post-transplant cardiovascular disease - Report and recommendations of an ad hoc group
    Bostom, AD
    Brown, RS
    Chavers, BM
    Coffman, TM
    Cosio, FG
    Culver, K
    Curtis, JJ
    Danovitch, GM
    Everson, GT
    First, MR
    Garvey, C
    Grimm, R
    Hertz, MI
    Hricik, DE
    Hunsicker, LG
    Ibrahim, H
    Kasiske, BL
    Kennedy, M
    Klag, M
    Knatterud, ME
    Kobashigawa, J
    Lake, JR
    Light, JA
    Matas, AJ
    McDiarmid, SV
    Miller, LW
    Payne, WD
    Rosenson, R
    Sutherland, DER
    Tejani, A
    Textor, S
    Valantine, HA
    Wiesner, RH
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) : 491 - 500
  • [5] Canzanello V J, 1997, Liver Transpl Surg, V3, P1
  • [6] Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506)
    Canzanello, VJ
    Textor, SC
    Taler, SJ
    Schwartz, LL
    Porayko, MK
    Wiesner, RH
    Krom, RAF
    [J]. LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (04): : 328 - 334
  • [7] Serum cholesterol changes in long-term survivors of liver transplantation:: A comparison between cyclosporine and tacrolimus therapy
    Charco, R
    Cantarell, C
    Vargas, V
    Capdevila, L
    Lázaro, JL
    Hidalgo, E
    Murio, E
    Margarit, C
    [J]. LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (03): : 204 - 208
  • [8] Weight change and obesity after liver transplantation: Incidence and risk factors
    Everhart, JE
    Lombardero, M
    Lake, JR
    Wiesner, RH
    Zetterman, RK
    Hoffnagle, JH
    [J]. LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (04): : 285 - 296
  • [9] The effects of maintenance doses of FK506 versus Cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation
    Fernandez, LA
    Lehmann, R
    Luzi, L
    Battezzati, A
    Angelico, MC
    Ricordi, C
    Tzakis, A
    Alejandro, R
    [J]. TRANSPLANTATION, 1999, 68 (10) : 1532 - 1541
  • [10] Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation
    Fernández-Miranda, C
    Sanz, M
    dela Calle, A
    Loinaz, C
    Gómez, R
    Jiménez, C
    García, I
    de la Cámara, AG
    Moreno, E
    [J]. TRANSPLANT INTERNATIONAL, 2002, 15 (11) : 556 - 562